13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • CS1003

    Acronym: 

    CS1003

    ACTRN/NCT /ethics: 

    NCT03475251

    Scientific title: 

    CUTANEOUS SQUAMOUS CELL CARCINOMA

    Summary of trial and patient characteristics

    Cancer Type All cancers
    Trial Type Treatment
    Phase Phase I Tumour Stream Solid Tumours
    Age Range 18 years and older Cancer Stage Locally Recurrent or Locally Advanced, Metastatic or Widespread
    Sex Both Anticipated Start Date 2018-05-09
    Molecular Target Anticipated End Date 2021-04-01
    Cancer Type All cancers
    Trial Type Treatment
    Phase Phase I
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Solid Tumours
    Cancer Stage Locally Recurrent or Locally Advanced, Metastatic or Widespread
    Anticipated Start Date 2018-05-09
    Anticipated End Date 2021-04-01

    Trial Summary

    CUTANEOUS SQUAMOUS CELL CARCINOMA

    Lay Summary

    CUTANEOUS SQUAMOUS CELL CARCINOMA

    Sponsor / Cooperative group

    Cstone

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Royal Adelaide Hospital Anne Milton anne.milton@sa.gov.au 08 7074 2342 Professor Michael Brown Recruiting
    Ashford Cancer Centre Research Sue Yeend syeend@adelaidecancercentre.com.au 08 8292 2240 Dr Sarwan Bishnoi Recruiting